Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-25-000136

Director sold 7,844 shares at $6.30 ($49,417)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Katkin Keith · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-23 Sale : show line 1 in the form 10b5-1 −7,844 $6.30 $49,417 86,431 D
Open-market sales · 7,844 sh · avg $6.30 · $49,417
Loading xslF345X05/wk-form4_1748462897.xml…